Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation
about
Rare gastrointestinal lymphomas: The endoscopic investigationSystematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisThe Changing Phenotype of Inflammatory Bowel DiseaseHigh Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseasesCancer and immunomodulators in inflammatory bowel diseases.Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, MinnesotaBetter survival of renal cell carcinoma in patients with inflammatory bowel diseaseThe association between human papillomavirus infection and female lung cancer: A population-based cohort study.Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Who and how to screen for cancer in at-risk inflammatory bowel disease patients.The epidemiology of inflammatory bowel disease.Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy.Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study.Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study.The Trend of Inflammatory Bowel Diseases in Taiwan: A Population-Based Study.DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review.Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.The safety of vedolizumab for ulcerative colitis and Crohn's disease.Co-existence of psoriasis and melanoma in a large urban academic centre population: a cross-sectional retrospective study.Risk of Lymphoma, Colorectal and Skin Cancer in Patients with IBD Treated with Immunomodulators and Biologics: A Quebec Claims Database Study.Clinical and endoscopic recurrence after surgical resection in patients with Crohn's diseaseChildhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014.Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis.Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.Cancer Risk in Patients with Intestinal Behçet's Disease: A Nationwide Population-Based Study.Incidence, management, and course of cancer in patients with inflammatory bowel disease.Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review.Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats
P2860
Q26799041-6E73EBDB-4CDB-4FE9-9799-574C65F0231BQ27011853-71D79936-17E6-4277-8CF5-2E7693254A9CQ28354092-477ECA0A-46C3-4B07-92E4-F4C9ABE434CFQ30977032-AC0030C8-C5EF-4183-AD10-624EA2F25E62Q33819473-DABB02CC-4B9C-4FB5-927F-4B043A256DBFQ34062402-64DCF160-4A9C-4423-B3B1-4AC0BA5CE556Q34173855-0FD85A24-3D31-4AE7-B291-25AF3CD0D20CQ35534959-639D65F1-24AE-4763-9C88-9087D678F4D4Q35690314-417E8D06-1574-44D6-A6D4-FA11B35CD375Q36546056-29AB26F6-062D-4DC4-9A46-017CB650A0FFQ37003703-88838F76-E7E2-45E6-8B8A-349504F6EC2CQ38238980-5F547AC1-212E-4B65-A3EF-D4F862C8DF50Q38253832-E392BFF6-1070-450B-9AA8-AB0A19A70E38Q38319989-FE115CDD-ECA7-4B60-B9B7-D9F64E6B36B5Q38357796-976D7EAE-5D90-44E7-A4E3-6FCB7DB17CE1Q38611360-B95F4F60-8731-4126-81F4-E5A6258EA580Q38814448-C6509C05-58EC-43B4-B988-9D9ABBF8D9D3Q38853741-3F182A13-3A9E-471E-9DF9-7FABE84E0EA8Q38883661-18F0DFBF-F853-4325-94A5-89A07220D20AQ39022125-0020E44A-3C2F-4C6B-9066-8D95972789B7Q39377846-8B4A34EB-DD96-4A0F-8400-6D35DA2558E0Q39773210-46AAA11A-8CD3-4908-950B-E335D9FCC130Q39985219-F448086B-1680-4931-853F-2562BF415F4BQ40252808-59FAD70A-5AF5-4F52-8F91-8FDCF8B5702CQ41726526-5CA1AB9C-6EC4-4BE2-822D-EA537FD6FD31Q41851680-CA8BEC99-35E4-4AB2-A59E-2293C1F80DA6Q42361133-18FBF739-C59C-474F-9195-6EC367809AA2Q43521204-9D837429-A936-43CC-9F0F-DA5FF461E89FQ47858365-F70F62B2-DFE2-4FF2-9625-A8FAA317F9ACQ49387119-D73FF204-BD13-4CA2-975B-B9A3647C5C4AQ50078662-2E13B6FB-9680-44B9-8E08-413BF0FCFF4BQ50451653-98B5C9D6-56BB-490A-BD4E-394794DDD379Q55690473-5AF4E3F4-1709-4118-A3F1-7BDD2C195F51Q57099324-A4963E54-3295-4797-9F13-8327F56B7AA7
P2860
Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk of cancer in patients wit ...... years of follow-up evaluation
@ast
Risk of cancer in patients wit ...... years of follow-up evaluation
@en
type
label
Risk of cancer in patients wit ...... years of follow-up evaluation
@ast
Risk of cancer in patients wit ...... years of follow-up evaluation
@en
prefLabel
Risk of cancer in patients wit ...... years of follow-up evaluation
@ast
Risk of cancer in patients wit ...... years of follow-up evaluation
@en
P2093
P2860
P50
P1476
Risk of cancer in patients wit ...... years of follow-up evaluation
@en
P2093
Dora K Farkas
John A Baron
Michael D Kappelman
Millie D Long
P2860
P304
P356
10.1016/J.CGH.2013.03.034
P407
P577
2013-04-17T00:00:00Z